How to Manage Febrile Neutropenia During the COVID Pandemic?

Saber Boutayeb; Ibrahim El Ghissassi; Hind Mrabti; Hassan Errihani

doi:10.1634/theoncologist.2020-0285

How to Manage Febrile Neutropenia During the COVID Pandemic?

Oncologist. 2020 Aug;25(8):e1251. doi: 10.1634/theoncologist.2020-0285. Epub 2020 May 27.

Authors

Saber Boutayeb¹, Ibrahim El Ghissassi¹, Hind Mrabti¹, Hassan Errihani¹

Affiliation

¹ Medical Oncology Department, National Institute of Oncology, Mohammed V University, Rabat, Morocco.

Abstract

This letter to the editor reflects on the recently published article about management of cancer patients during the COVID‐19 pandemic by Al‐Shamsi et al., specifically as regards the management of febrile neutropenia in the context of the pandemic.

Publication types

Letter
Comment

MeSH terms

Betacoronavirus
COVID-19
Coronavirus Infections*
Coronavirus*
Febrile Neutropenia* / drug therapy
Febrile Neutropenia* / epidemiology
Humans
Neoplasms* / complications
Neoplasms* / epidemiology
Pandemics*
Pneumonia, Viral*
SARS-CoV-2